Purinergic Signalling in Parkinson’s Disease: A Multi-target System to Combat Neurodegeneration
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-6903
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Purinergic Signalling in Parkinson’s Disease: A Multi-target System to Combat Neurodegeneration ; day:4 ; month:5 ; year:2019 ; pages:1-10
Neurochemical research ; (4.5.2019), 1-10
- Creator
-
Tóth, Adrián
Antal, Zsófia
Bereczki, Dániel
Sperlágh, Beáta
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11064-019-02798-1
- URN
-
urn:nbn:de:101:1-2019061921360697409943
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tóth, Adrián
- Antal, Zsófia
- Bereczki, Dániel
- Sperlágh, Beáta
- SpringerLink (Online service)
Other Objects (12)
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Molekulare Mechanismen der Neurodegeneration bei Morbus Parkinson
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
GPR37 processing in neurodegeneration: a potential marker for Parkinson’s Disease progression rate
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Author Correction: Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
Serum neurofilament indicates accelerated neurodegeneration and predicts mortality in late-stage Parkinson’s disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson’s disease model
Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration
Parkinson's and Alzheimer's today : about neurodegeneration and its therapy
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Molekulare Mechanismen der Neurodegeneration bei Morbus Parkinson
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
GPR37 processing in neurodegeneration: a potential marker for Parkinson’s Disease progression rate
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Author Correction: Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
Serum neurofilament indicates accelerated neurodegeneration and predicts mortality in late-stage Parkinson’s disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson’s disease model
Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration
Parkinson's and Alzheimer's today : about neurodegeneration and its therapy
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Molekulare Mechanismen der Neurodegeneration bei Morbus Parkinson
Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson’s disease
Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
GPR37 processing in neurodegeneration: a potential marker for Parkinson’s Disease progression rate
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Author Correction: Two distinct trajectories of clinical and neurodegeneration events in Parkinson’s disease
Serum neurofilament indicates accelerated neurodegeneration and predicts mortality in late-stage Parkinson’s disease
Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson’s disease mouse model
Integrin CD11b mediates locus coeruleus noradrenergic neurodegeneration in a mouse Parkinson’s disease model
Alpha-synuclein-induced stress sensitivity renders the Parkinson’s disease brain susceptible to neurodegeneration